Nephromics (U.S. royalty obligation and worldwide diagnostics assets) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- Asset Purch.
- Financing Rounds
- 1
Nephromics (U.S. royalty obligation and worldwide diagnostics assets) General Information
Description
U.S. royalty obligation and rights of worldwide diagnostics assets of Nephromics. The license is for tests related to the detection, monitoring and risk assessment of preeclampsia, a leading cause of maternal death.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Acquirer
Primary Office
- Chestnut Hill, MA
- United States
Nephromics (U.S. royalty obligation and worldwide diagnostics assets) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.
Request a free trialNephromics (U.S. royalty obligation and worldwide diagnostics assets) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Nephromics (U.S. royalty obligation and worldwide diagnostics assets)‘s full profile, request access.
Request a free trial